NGMBIO Trademark

Trademark Overview


On Monday, November 15, 2021, a trademark application was filed for NGMBIO with the United States Patent and Trademark Office. The USPTO has given the NGMBIO trademark a serial number of 97124968. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, November 18, 2024. This trademark is owned by NGM Biopharmaceuticals, Inc.. The NGMBIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders

Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
ngmbio

General Information


Serial Number97124968
Word MarkNGMBIO
Filing DateMonday, November 15, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, November 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Description of MarkThe mark consists of the combined words "ngmBIO" with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding medical information relating to cancer, retinal diseases and liver and metabolic diseases
NOT AVAILABLE"BIO"
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNGM Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameNGM Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 4, 2022ASSIGNED TO EXAMINER
Monday, August 8, 2022NON-FINAL ACTION WRITTEN
Monday, August 8, 2022NON-FINAL ACTION E-MAILED
Monday, August 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 1, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023NON-FINAL ACTION E-MAILED
Friday, March 17, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, March 17, 2023EXAMINERS AMENDMENT E-MAILED
Friday, March 17, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, March 18, 2023ASSIGNED TO LIE
Saturday, March 18, 2023EXAMINER'S AMENDMENT ENTERED
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 17, 2023SOU EXTENSION 1 FILED
Friday, November 17, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 23, 2024SOU EXTENSION 2 FILED
Thursday, May 23, 2024SOU EXTENSION 2 GRANTED
Friday, May 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2024SOU EXTENSION 3 FILED
Monday, November 18, 2024SOU EXTENSION 3 GRANTED